Quick Answer
Pea Protein Muscle Recovery Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Background This randomized, double-blind, placebo-controlled trial examined the effects of a chickpea protein hydrolysate (CPH) on biomarkers associated with exercise-induced muscle damage and inflammation in federated male road cyclists.
Key Takeaways
- 01Background This randomized, double-blind, placebo-controlled trial examined the effects of a chickpea protein hydrolysate (CPH) on biomarkers associated with exercise-induced muscle damage and inflammation in federated male road cyclists. [García-Durán J (2026)]
- 02LDH decreased in the EXP group while increasing slightly in the placebo group, whereas CRP decreased in EXP and increased in PLA. [García-Durán J (2026)]
- 03The high baseline protein intake (>2 g/kg/day) and short intervention duration may have limited changes in body composition, nevertheless, the observed biomarker responses suggest that CPH supplementation may influence selected physiological processes associated with exercise-induced inflammation and cellular stress. [García-Durán J (2026)]
- 04Methods Twenty-four participants completed a 14-day intervention receiving either 12 g/day of chickpea protein hydrolysate (EXP) or a placebo (PLA) following training sessions. [García-Durán J (2026)]
The current Migaku evidence database contains 2 reusable source documents for Pea Protein Muscle Recovery Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation.
- Background This randomized, double-blind, placebo-controlled trial examined the effects of a chickpea protein hydrolysate (CPH) on biomarkers associated with exercise-induced muscle damage and inflammation in federated male road cyclists. [García-Durán J (2026); evidence level 4]
- LDH decreased in the EXP group while increasing slightly in the placebo group, whereas CRP decreased in EXP and increased in PLA. [García-Durán J (2026); evidence level 4]
- The high baseline protein intake (>2 g/kg/day) and short intervention duration may have limited changes in body composition, nevertheless, the observed biomarker responses suggest that CPH supplementation may influence selected physiological processes associated with exercise-induced inflammation and cellular stress. [García-Durán J (2026); evidence level 4]
- Methods Twenty-four participants completed a 14-day intervention receiving either 12 g/day of chickpea protein hydrolysate (EXP) or a placebo (PLA) following training sessions. [García-Durán J (2026); evidence level 4]
- We establish a structured framework to separately report evidence from preclinical animal models and clinical human trials, evaluating acute ( 7 days) horizons across three domains: (i) neurocognitive function/mood, (ii) gut microbiota/hormonal responses, and (iii) aminoacidemia/metabolic-inflammatory responses in aging cohorts. [Hao S (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Effects of a chickpea protein hydrolysate on exercise-induced biomarkers of muscle damage and inflammation in federated road cyclists.
- Comparative effects of pea protein vs. dairy proteins (α-lactalbumin and casein) on aminoacidemia, exercise performance, gut microbiota, hormonal responses, neurocognitive function, mood, and metabolic-inflammatory responses in older adults.